BIOVERATIV INC. Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
BIOVERATIV INC. reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of $355.60 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-14.
Discontinued › Income Statement › Net Income
us-gaap:ProfitLoss · last filed 2018-02-14
- BIOVERATIV INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2017-12-31 was $141.30M, a 38.27% decline year-over-year.
- BIOVERATIV INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2017-09-30 was $67.90M, a 15.65% decline year-over-year.
- BIOVERATIV INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2016-12-31 was $228.90M.
- BIOVERATIV INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2016-09-30 was $80.50M.
- BIOVERATIV INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2017 was $355.60M, a 19.11% decline from fiscal 2016.
- BIOVERATIV INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2016 was $439.60M, a 304.79% increase from fiscal 2015.
- BIOVERATIV INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2015 was $108.60M.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2017-12-31 | $141.30M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-14 | $209.20M derived: sum of 2 quarters · filed 2018-02-14 | $355.60M 10-K · filed 2018-02-14 | |
| 2017-09-30 | $67.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-27 | $214.30M 10-Q · filed 2017-10-27 | ||
| 2017-06-30 | $146.40M 10-Q · filed 2017-08-03 | |||
| 2016-12-31 | $228.90M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-14 | $309.40M derived: sum of 2 quarters · filed 2018-02-14 | $439.60M 10-K · filed 2018-02-14 | |
| 2016-09-30 | $80.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-27 | $210.70M 10-Q · filed 2017-10-27 | ||
| 2016-06-30 | $130.20M 10-Q · filed 2017-08-03 | |||
| 2015-12-31 | $108.60M 10-K · filed 2018-02-14 |